Survey for assessment of expertise and services for paedatric clinical research in Europe
Many initiatives in Europe are promoting the creation and implementation of a European Paediatric Clinical Trials Centres Networks and Infrastructures. In this scenario, an online survey has been developed by several experts referring to the TEDDY Network (European Network of Excellence for Paediatric Clinical Research) with particular input from FINPEDMED (the Finnish Investigators Network for Paediatric Medicines) and in collaboration with INCiPiT (Italian Network for Paediatric Clinical Trials). It was agreed with EnprEMA (the European Network of Paediatric Research at the European Medicines Agency), which includes 43 paediatric networks.
The information will be used to design networks and to attract funding for national and specialty networks. The survey seeks information about the expertise of centres performing paediatric clinical trials and the services available, the equipment and the centralised services that support clinical trials in each site. The survey will be sent to sites across Europe and will map the European scenario of paediatric clinical research in the light of the potential setup of a research infrastructure for the conduction of paediatric clinical trials.
The questionnaire is composed by 60 questions, most of them are multiple-choice questions and should take about 20 minutes to be completed.
If your hospital/ research centre has experience with paediatric clinical research, please contact usat the following e-mail address: firstname.lastname@example.org would be glad to send you the link to fill in the survey.
The results of the survey will be published on the TEDDY website.
EPMD is a database containing information on paediatric drugs authorised by the European Medicines Agency (EMA) under the centralised procedure. It is aimed to create a harmonised, integrated and reliable European source of information by collecting data from different sources (national authorities, regulatory bodies, pharmaceutical companies). It is an useful instrument to provide all the stakeholders with appropriate information concerning the rational use of paediatric medicines and to identify unmet medical needs in paediatrics: healthcare professionals, institutional bodies, companies, patients’ associations and families can freely access to the database.
A report about information on EMA authorised drugs with a paediatric indication is periodically produced and disseminated throughout the Network. The last report is available here in PDF format:
Results from two TEDDY surveys investigating the national and local level of the ethic procedures applied in Europe with reference to pediatric trials approval. The surveys have been conducted following an inventory of:
the Competent National Authorities and
the Ethics Committees operating in Europe with all the website addresses and contact details.